Finepoint Capital’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$8.58K Hold
2024
Q2
$27.6K Hold
2024
Q1
$34.1K Hold
2023
Q4
$32.8K Hold
2023
Q3
$144K Hold
2023
Q2
$85.2K Hold
2023
Q1
$26.9K Hold
2022
Q4
$33K Hold
2022
Q3
$37K Hold
2022
Q2
$59K Hold
2022
Q1
$236K Hold
2021
Q4
$328K Buy